The Hospital das Clínicas da Unicamp is a teaching hospital located in the city of Campinas, state of São Paulo, Brazil. The largest public hospital in the region, it serves a population around 3.5 million people. It is a tertiary hospital, with all the medical specialties and medico-surgical services represented.

During the past decade, Hospital das Clinicas - UNICAMP conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 7 clinical trials were completed, i.e. on average, 25.9% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 4 clinical trials were completed. i.e. 23.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital das Clinicas - UNICAMP" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "University of Campinas, Brazil" with 6 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored, "Takeda" with 3 trials sponsored and "Hospital de Clinicas de Porto Alegre" with 3 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital das Clinicas - UNICAMP" #1 collaborator was "Ministry of Health, Brazil" with 3 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "University of Campinas, Brazil" with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator and "Brainomix Limited" with 1 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Hospital das Clinicas - UNICAMP" are "Arthritis, Rheumatoid" (2 trials), "COVID-19" (2 trials), "Dravet Syndrome (DS)" (2 trials), "Juvenile Idiopathic Arthritis" (2 trials) and "Lennox Gastaut Syndrome (LGS)" (2 trials). Many other conditions were trialed in "Hospital das Clinicas - UNICAMP" in a lesser frequency.

Most popular intervention types in "Hospital das Clinicas - UNICAMP" are "Drug" (27 trials), "Biological" (4 trials), "Procedure" (4 trials), "Device" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Baricitinib" (4 trials), "Ocrelizumab" (3 trials), "Soticlestat" (3 trials) and "Methylprednisolone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital das Clinicas - UNICAMP" are 37 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital das Clinicas - UNICAMP". undefined are not yet recruiting, 13 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Hospital das Clinicas - UNICAMP, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital das Clinicas - UNICAMP, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 4 trials that are defined as “Not Applicable".